Skip to content

Medical Information for Clinicians

Citations of peer-reviewed articles from leading medical journals that present evidence in support of clinical strategies to preempt allogeneic blood transfusion in a variety of medical and surgical settings.

Contact Us

Featured Articles

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. (opens new window)

Della Porta MG, Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcárcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Pilot R, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Prebet T, Lai Y, Degulys A, Paolini S, Cluzeau T, Fenaux P, Platzbecker U

Source‎: Lancet Haematol 2024;11(9):e646-58.

Indexed‎: PubMed 39038479

DOI‎: 10.1016/S2352-3026(24)00203-5

https://pubmed.ncbi.nlm.nih.gov/39038479/ (opens new window)

Clinical Strategies

Medicine and Surgery

Clinical strategies for managing hemorrhage and anemia without allogeneic blood transfusion.

Pediatrics

Clinical strategies for managing neonatal and pediatric patients without allogeneic blood transfusion.

Diseases and Conditions

Clinical strategies for managing specific diseases or conditions without allogeneic blood transfusion.

Bioethics and Law

Ethical, legal, and social factors for health-care professionals to consider when treating Jehovah’s Witnesses.

Contact Local Representative

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.